Company intelligence / Profile preview

Prolytix

Essex Junction, Vermont, United Statesgoprolytix.com ↗

Ownership: Private
Development stage: Other

Overview

Prolytix is an established contract research organization (CRO) specializing in large molecule analytics for biotherapeutic drug development. With over 35 years of experience rooted in protein chemistry and hemostasis, it offers comprehensive support from discovery through commercial release. The company is recognized for its expertise in method development/validation, GMP/GLP/CLIA-certified testing labs, stability studies, research reagents supply (notably plasma proteins), custom collection devices, and process development for biologics including recombinant proteins and antibodies.

Modalities: Recombinant proteinMonoclonal antibodyBispecific monoclonal antibodyPlasma-derived therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Prolytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolytix.

Explore the full profile